Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current and future modalities for functional renal replacement.

G E Amiel1, A Atala

  • 1Department of Urology, Children's Hospital, Boston, Massachusetts, USA.

The Urologic Clinics of North America
|March 23, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of urology residency training between the United States and China.

Actas urologicas espanolas·2022
Same author

Ibuprofen loaded PLA nanofibrous scaffolds increase proliferation of human skin cells in vitro and promote healing of full thickness incision wounds in vivo.

Journal of biomedical materials research. Part B, Applied biomaterials·2015
Same author

Assessments of injectable alginate particle-embedded fibrin hydrogels for soft tissue reconstruction.

Biomedical materials (Bristol, England)·2013
Same author

Decellularization for whole organ bioengineering.

Biomedical materials (Bristol, England)·2013
Same author

Controlled heparin conjugation on electrospun poly(ε-caprolactone)/gelatin fibers for morphology-dependent protein delivery and enhanced cellular affinity.

Acta biomaterialia·2012
Same author

Embryoid body formation of human amniotic fluid stem cells depends on mTOR.

Oncogene·2009
Same journal

An Unprecedented Era of Innovation in Non-Muscle-Invasive Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Hubert Humphrey's Bladder Cancer: If He Could Have Time Traveled, Would that Have Changed the Outcome?

The Urologic clinics of North America·2026
Same journal

Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management.

The Urologic clinics of North America·2026
Same journal

Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care.

The Urologic clinics of North America·2026
Same journal

Economic Considerations in the Management of Superficial Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care.

The Urologic clinics of North America·2026
See all related articles

Advances in dialysis, transplantation, and cell-based therapies are improving survival for patients with end-stage renal disease. Future innovations aim to further enhance kidney function replacement and treatment efficacy.

Area of Science:

  • Nephrology
  • Transplantation Immunology
  • Biomaterials Science

Background:

  • Over 310,000 Americans have end-stage renal disease (ESRD), with 70,000+ new cases annually.
  • Improved immunosuppression and dialysis care have increased survival rates for renal failure patients.

Purpose of the Study:

  • To review recent advancements in renal failure treatment.
  • To explore future directions in dialysis, transplantation, and regenerative medicine for kidney function replacement.

Main Methods:

  • Review of current literature on immunosuppressive therapy, dialysis, organ transplantation, and xenotransplantation.
  • Analysis of emerging technologies in cell harvesting, expansion, and synthetic biomaterials for renal units.

Main Results:

Related Experiment Videos

  • Significant improvements in patient survival due to enhanced immunosuppression and dialysis.
  • Progress in organ transplantation, graft rejection understanding, and surgical/medical management.
  • Early successes in in vitro renal cell expansion and development of functional 3D renal units.

Conclusions:

  • Ongoing developments in dialysis and transplantation continue to improve outcomes for renal failure patients.
  • Renal xenotransplantation shows promise, though still in early development.
  • In vitro cell expansion and biomaterial advancements pave the way for novel ex vivo and in vivo kidney function replacement strategies.